“The global high-throughput screening market size is projected to reach USD 44.5 billion by 2028 from USD 25.6 billion in 2023, at a CAGR of 11.6% during the forecast period.”
Increase in government funding and venture capital investments is one of the high impact drivers of the high throughput screening market. In March 2023, Iktos, a company specializing in artificial intelligence for new drug discovery, today announces the closing of a 15.5 million euros (USD 16 Mn) Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. This financing will enable the company to further develop its AI and drug discovery capabilities and expand its existing SaaS software offering, in addition to launching Iktos Robotics.
“The services segment is set to register highest growth rate during 2023-2028 in HTS market”
The high-throughput screening market is segmented into consumables, instruments, , services, and software. HTS services have emerged as a lucrative market space, with fastest growth in the market registered through the forecast period. Routine adoption of outsourcing of HTS services by pharmaceutical companies, including lead identification, screening, toxicology, and other preclinical studies contributes to the segment growth.
“CRO end user segment is set to witness the highest growth rate in the HTS market”
Based on end user , the high-throughput screening market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. The key factor driving the growth of this segment includes trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies. In recent years, due to the enormous pressure to contain fixed costs, outsourcing has evolved as a strategic alternative for pharmaceutical & biopharmaceutical companies due to the lack of in-house resources required for new product development and the need for cost & time savings.
“Drug Discovery segment accounted for the highest CAGR”
Based on application , the high-throughput screening market is segmented into drug discovery, biochemical screening, life sciences research and other applications. The drug discovery segment is set to grow at the fastest pace throughout 2023 to 2028. The key factor driving this segment’s growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Continuous advancements in HTS technologies, such as automation, miniaturization, and high-content screening, are impacting the growth of the segment. Automation enables the handling and screening of large compound libraries with high precision and throughput, improving efficiency and reducing costs.
“Asia Pacific: The fastest-growing country in the high-throughput screening market”
The high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America, and the MEA. Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Supply side- 80%, Demand side-20%
• By Designation: C-level – 45%, D-level – 30%, and Others – 25%
• By Region: Asia-Pacific -55%, North America -20%, Europe -10%, Latin America-10%, Middle East and Africa-5%
Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• PerkinElmer, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• AXXAM S.p.A (Italy)
• Promega Corporation (US)
• Bio-Rad Laboratories, Inc.(US)
• Promega Corporation (US)
• Hamilton Company (US)
• Corning Incorporated (US)
• Charles River Laboratories (US)
• Lonza (Switzerland)
• REPROCELL Inc. (Japan)
• Aurora Biomed (Canada)
• BMG LABTECH (Germany)
• DIANA Biotechnologies, s.r.o. (Czech Republic)
• NanoTemper Technologies GmbH (Germany)
• Creative Biolabs (US)
• Biomat Srl (Italy)
Research Coverage:
This report provides a detailed picture of the high throughput screening market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report provides insights on the following pointers:
• Analysis of key drivers (the growing adoption of open innovative models in pharmaceutical & biotechnology companies, government funding and venture capital investments, increasing R&D spending, and technological advancements), restraints (high costs of using HTS instruments, and complexities in assay development), oppotunities (increasing adoption of HTS technologies in emerging markets, and growing applications in stem cell research), and challenges (dearth of skilled operators, and complexities in data analysis and management) influencing the growth of the HTS market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the HTS market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various high-throughput screening across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high-throughput screening market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players like Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), among others in the high-throughput screening market.
10.3 EUROPE 207
10.3.1 EUROPE: RECESSION IMPACT 207
TABLE 252 EUROPE: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 253 EUROPE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 208
TABLE 254 EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 255 EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 256 EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 209
TABLE 257 EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 258 EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 259 EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 260 EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 261 EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 262 EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 263 EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 264 EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 212
10.3.2 GERMANY 212
10.3.2.1 Increasing research activity to favor demand for screening solutions 212
TABLE 265 GERMANY: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 213
TABLE 266 GERMANY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 267 GERMANY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 268 GERMANY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 214
TABLE 269 GERMANY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 270 GERMANY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 271 GERMANY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 272 GERMANY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 273 GERMANY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 274 GERMANY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 275 GERMANY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 216
TABLE 276 GERMANY: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 216
10.3.3 UK 217
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to support market 217
FIGURE 32 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 217
TABLE 277 UK: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 218
TABLE 278 UK: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 279 UK: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 280 UK: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 219
TABLE 281 UK: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 282 UK: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 283 UK: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 284 UK: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 285 UK: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 286 UK: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 287 UK: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 221
TABLE 288 UK: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 221
10.3.4 FRANCE 222
10.3.4.1 Large pharmaceutical manufacturing industry to drive market 222
TABLE 289 FRANCE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 222
TABLE 290 FRANCE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 291 FRANCE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 292 FRANCE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 223
TABLE 293 FRANCE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 294 FRANCE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 295 FRANCE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 296 FRANCE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 297 FRANCE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 298 FRANCE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 299 FRANCE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 225
TABLE 300 FRANCE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 226
10.3.5 ITALY 226
10.3.5.1 Strong collaborative research networks to fuel growth 226
TABLE 301 ITALY: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 226
TABLE 302 ITALY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 303 ITALY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 304 ITALY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 227
TABLE 305 ITALY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 306 ITALY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 307 ITALY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 308 ITALY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 309 ITALY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 310 ITALY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 311 ITALY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 312 ITALY: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 230
10.3.6 SPAIN 230
10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to drive market 230
TABLE 313 SPAIN: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 231
TABLE 314 SPAIN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 315 SPAIN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 316 SPAIN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 232
TABLE 317 SPAIN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 318 SPAIN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 319 SPAIN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 320 SPAIN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 321 SPAIN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 322 SPAIN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 323 SPAIN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 324 SPAIN: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 234
10.3.7 REST OF EUROPE 235
TABLE 325 REST OF EUROPE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 235
TABLE 326 REST OF EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 327 REST OF EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 328 REST OF EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 236
TABLE 329 REST OF EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 330 REST OF EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 331 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 332 REST OF EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 333 REST OF EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 334 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 335 REST OF EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 238
TABLE 336 REST OF EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 239
10.4 ASIA PACIFIC 239
10.4.1 ASIA PACIFIC: RECESSION IMPACT 239
FIGURE 33 ASIA PACIFIC: HTS MARKET SNAPSHOT 240
TABLE 337 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 241
TABLE 338 ASIA PACIFIC: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 241
TABLE 339 ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 340 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 341 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 242
TABLE 342 ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 343 ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 344 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 345 ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 346 ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 347 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 348 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 244
TABLE 349 ASIA PACIFIC: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 245
10.4.2 CHINA 245
10.4.2.1 Presence of key CROs to favor market growth 245
TABLE 350 CHINA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 246
TABLE 351 CHINA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 352 CHINA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 353 CHINA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 247
TABLE 354 CHINA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 355 CHINA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 356 CHINA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 357 CHINA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 358 CHINA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 359 CHINA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 360 CHINA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 249
TABLE 361 CHINA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 249
10.4.3 JAPAN 250
10.4.3.1 Rising prominence of regenerative medicine research to drive market 250
TABLE 362 JAPAN: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 363 JAPAN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 364 JAPAN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 365 JAPAN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 251
TABLE 366 JAPAN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 367 JAPAN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 368 JAPAN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 369 JAPAN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 370 JAPAN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 371 JAPAN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 372 JAPAN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 254
TABLE 373 JAPAN: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 254
10.4.4 INDIA 254
10.4.4.1 Low-cost services and strong government support to propel market 254
TABLE 374 INDIA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 255
TABLE 375 INDIA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 376 INDIA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 377 INDIA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 256
TABLE 378 INDIA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 379 INDIA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 380 INDIA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 381 INDIA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 382 INDIA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 383 INDIA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 384 INDIA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 258
TABLE 385 INDIA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 259
10.4.5 REST OF ASIA PACIFIC 259
TABLE 386 REST OF ASIA PACIFIC: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 260
TABLE 387 REST OF ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 388 REST OF ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 389 REST OF ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 261
TABLE 390 REST OF ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 391 REST OF ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 392 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 393 REST OF ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 394 REST OF ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 395 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 396 REST OF ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 397 REST OF ASIA PACIFIC: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 263
10.5 LATIN AMERICA 264
10.5.1 LATIN AMERICA: RECESSION IMPACT 264
TABLE 398 LATIN AMERICA: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 399 LATIN AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 265
TABLE 400 LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 401 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 402 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 266
TABLE 403 LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 404 LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 405 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 406 LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 407 LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 408 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 409 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 268
TABLE 410 LATIN AMERICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 268
10.5.2 BRAZIL 269
10.5.2.1 Rising research activity to contribute to growth 269
TABLE 411 BRAZIL: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 269
TABLE 412 BRAZIL: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 413 BRAZIL: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 414 BRAZIL: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 270
TABLE 415 BRAZIL: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 416 BRAZIL: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 417 BRAZIL: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 418 BRAZIL: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 419 BRAZIL: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 420 BRAZIL: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 421 BRAZIL: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 272
TABLE 422 BRAZIL: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 273
10.5.3 REST OF LATIN AMERICA 273
TABLE 423 REST OF LATIN AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 273
TABLE 424 REST OF LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 425 REST OF LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 426 REST OF LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 274
TABLE 427 REST OF LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 428 REST OF LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 429 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 430 REST OF LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 431 REST OF LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 432 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 433 REST OF LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 277
TABLE 434 REST OF LATIN AMERICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 277
10.6 MIDDLE EAST & AFRICA 277
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 277
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 278
TABLE 435 MIDDLE EAST & AFRICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 278
TABLE 436 MIDDLE EAST & AFRICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 437 MIDDLE EAST & AFRICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 438 MIDDLE EAST & AFRICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 279
TABLE 439 MIDDLE EAST & AFRICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 440 MIDDLE EAST & AFRICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 441 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 442 MIDDLE EAST & AFRICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 443 MIDDLE EAST & AFRICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 444 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 445 MIDDLE EAST & AFRICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 282
TABLE 446 MIDDLE EAST & AFRICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 282
11 COMPETITIVE LANDSCAPE 283
11.1 INTRODUCTION 283
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 284
FIGURE 34 HTS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 284
11.3 REVENUE SHARE ANALYSIS 285
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 285
11.4 MARKET SHARE ANALYSIS 286
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 286
TABLE 447 HTS MARKET: DEGREE OF COMPETITION 286
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 287
11.5.1 STARS 288
11.5.2 EMERGING LEADERS 288
11.5.3 PERVASIVE PLAYERS 288
11.5.4 PARTICIPANTS 288
FIGURE 37 HTS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 289
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 290
TABLE 448 COMPANY FOOTPRINT ANALYSIS (KEY PLAYERS) 290
TABLE 449 PRODUCT FOOTPRINT ANALYSIS (KEY PLAYERS) 291
TABLE 450 REGIONAL FOOTPRINT ANALYSIS (KEY PLAYERS) 292
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 293
11.7.1 PROGRESSIVE COMPANIES 293
11.7.2 STARTING BLOCKS 293
11.7.3 RESPONSIVE COMPANIES 293
11.7.4 DYNAMIC COMPANIES 293
FIGURE 38 HTS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 294
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 295
TABLE 451 HTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 295
TABLE 452 HTS MARKET: COMPETITIVE BENCHMARKING OF START- UPS/SMES 296
11.9 COMPETITIVE SCENARIOS AND TRENDS 297
11.9.1 PRODUCT LAUNCHES 297
TABLE 453 HTS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023 297
11.9.2 DEALS 298
TABLE 454 HTS MARKET: DEALS, JANUARY 2020–MAY 2023 298
11.9.3 OTHER DEVELOPMENTS 298
TABLE 455 HTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023 298
12 COMPANY PROFILES 299
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY COMPANIES 299
12.1.1 THERMO FISHER SCIENTIFIC, INC. 299
TABLE 456 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 299
FIGURE 39 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 300
12.1.2 AGILENT TECHNOLOGIES, INC. 305
TABLE 457 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 305
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 306
12.1.3 MERCK KGAA 312
TABLE 458 MERCK KGAA: BUSINESS OVERVIEW 312
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) 313
12.1.4 DANAHER CORPORATION 316
TABLE 459 DANAHER CORPORATION: BUSINESS OVERVIEW 316
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 317
12.1.1 PERKINELMER, INC. 321
TABLE 460 PERKINELMER, INC.: BUSINESS OVERVIEW 321
FIGURE 43 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 322
12.1.2 TECAN TRADING AG 326
TABLE 461 TECAN TRADING AG: BUSINESS OVERVIEW 326
FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022) 327
12.1.3 AXXAM S.P.A 330
TABLE 462 AXXAM S.P.A: BUSINESS OVERVIEW 330
12.1.4 BIO-RAD LABORATORIES, INC. 333
TABLE 463 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 333
FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 334
12.1.5 PROMEGA CORPORATION 337
TABLE 464 PROMEGA CORPORATION: BUSINESS OVERVIEW 337
12.1.6 CORNING INCORPORATED 339
TABLE 465 CORNING INCORPORATED: BUSINESS OVERVIEW 339
FIGURE 46 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 340
12.1.7 CHARLES RIVER LABORATORIES 342
TABLE 466 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 342
FIGURE 47 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 343
12.1.8 EUROFINS SCIENTIFIC 345
TABLE 467 EUROFINS SCIENTIFIC COMPANY: BUSINESS OVERVIEW 345
FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 345
12.1.9 HAMILTON COMPANY 348
TABLE 468 HAMILTON COMPANY: BUSINESS OVERVIEW 348
12.1.10 LONZA 351
TABLE 469 LONZA: BUSINESS OVERVIEW 351
FIGURE 49 LONZA: COMPANY SNAPSHOT (2022) 352
12.1.11 REPROCELL, INC. 354
TABLE 470 REPROCELL, INC.: BUSINESS OVERVIEW 354
12.1.12 AURORA BIOMED 356
TABLE 471 AURORA BIOMED: BUSINESS OVERVIEW 356
12.2 OTHER PLAYERS 357
12.2.1 BMG LABTECH 357
12.2.2 DIANA BIOTECHNOLOGIES S.R.O. 358
12.2.3 NANOTEMPER TECHNOLOGIES GMBH 358
12.2.4 CREATIVE BIOLABS 359
12.2.5 BIOMAT SRL 359
12.2.6 HIGHRES BIOSOLUTIONS 360
12.2.7 CYCLICA, INC. 361
12.2.8 CROWN BIOSCIENCE 362
12.2.9 SYGNATURE DISCOVERY 363
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 364
13.1 DISCUSSION GUIDE 364
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370
13.3 CUSTOMIZATION OPTIONS 372
13.4 RELATED REPORTS 372
13.5 AUTHOR DETAILS 373
*** 免責事項 ***https://www.globalresearch.co.jp/disclaimer/